OPTOGENETICS and Caged compounds

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Driving fast-spiking cells induces gamma rhythm and controls sensory responses Driving fast-spiking cells induces gamma rhythm and controls sensory responses.
Neurobiology, Optogenetics, and Optics Ravi Nath 2015/02/10.
Abstract Optogenetics is genetically encoded, optically induced, control of cells through transgenic expression of microbial opsins in electrically excitable.
Review: General Control Theory
Cortically OriginatedMovement Cortically Originated Movement I. Motor Tract (corticospinal tractus) Extrapyramidal System (basal ganglia) Cerebellum Praxis.
Parkinson's Disease Animal Models and Possible Treatments.
Basal Ganglia and Motor Control L21
Temporally precise in vivo control of intracellular signaling pathways through optogene expression By: Michael DeSalvio Bio 570 September 24, 2010.
The Nervous System A network of billions of nerve cells linked together in a highly organized fashion to form the rapid control center of the body. Functions.
Brain Control of Movement. Motor Control Hierarchy  High level – plans and executes strategy Association areas of cortex Basal ganglia gives the “go”
Drugs Used to Treat Parkinson’s Disease By Jasmine and Morgan 11/13/03.
The dopaminergic reward system
Neural Control of Muscle. Quick Review: Spinal Cord Flexors Extensors.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Assess Prof. Fawzia Al-Rouq Department of Physiology College of Medicine King Saud University Functional Anatomy of the Nervous System.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
Pyramidal and extrapyramidal tracts
Optogenetic regulation of Ca 2+ signaling April 15, 2013 Class objectives: What is optogenetics? Mammalian rhodopsin. Biophysics of channelrhodopsin-2.
Some Terminologies White matter : myelinated fibre tracts White matter : myelinated fibre tracts Gray matter : areas of neuronal cell bodies Gray matter.
AP Biology Nervous Systems Part 2. Important concepts from previous units: Energy can be associated with charged particles, called ions. Established concentration.
Optogenetics1 Consolato Sergi, M.D., Ph.D. University of Alberta Hospital.
Making Things Happen - 2 Motor Disorders How Your Brain Works - Week 7 Dr. Jan Schnupp HowYourBrainWorks.net.
MODELING THE PARKINSONIAN TREMOR AND ITS TREATMENT Supervisor : Dr Towhidkhah Designed by Yashar Sarbaz Amirkabir University of Technology.
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
Brain Motor Control Lesson 20. Hierarchical Control of Movement n Association cortices & Basal Ganglia l strategy : goals & planning l based on integration.
Since Last Discussion: XII: Experience and Critical Periods (aka, Plastics) XIII: Brain Diseases I XIV: Brain Diseases II XV: Genetics and Human Brains:
The Neurological Control of Movement
Cognitive Psychology PSYC231 Cognition and the Brain: Basic Principles 2 Dr. Jan Lauwereyns, EA619, ext
Optogenetics: What you see is what you think
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Anita Mahadevan-Jansen Faraz Ali James Lugge Ernest Moore Mahesh Parlikad.
Chapter 8 The Neurological Control of Movement. Levels of Control of Movement Movements can range from simple to complex: The simplest movements are reflexive.
Figure 18.1 Motor components of the human basal ganglia.
Not a response to reward itself, but to information about reward More than predicted in ‘previous state’ = increased activity; positive prediction.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Pathogenesis and pathology of parkinsonism
STRUCTURE AND CIRCUITS OF THE BASAL GANGLIA Rastislav Druga Inst. of Anatomy, 2nd Medical Faculty.
Cell Signaling (BIO-203) Lecture 3. Types of G proteins Humans have 21 different G α subunits 6 G β subunits 12 G γ subunits Different G βγ function similarly.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Brain Mechanisms of Movement Lecture 19. Hierarchical Control of Movement n Association cortices & Basal Ganglia l strategy : goals & planning l based.
Optogenetics, Nucleus Accumbens and Parkinson’s Disease Deb Perkins-Hicks Optogenetics in the Nucleus Accumbens Spring 2016.
Optogenetics, Engrams, and Total Recall. clips/total-recall/something-more Objective vs subjective reality In 3 minutes.
Optogenetics An Introduction.
Parkinson’s Disease.
Module 7.3 Movement Disorders
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Basal ganglia function
1st Breaking Video IT_Pro 27/11/2018 Optogenetics.
Silencing Neurons: Tools, Applications, and Experimental Constraints
Dynamic Nigrostriatal Dopamine Biases Action Selection
Stimulating Neurons electrical stimulation with an electrode to bring neuron above AP threshold depolarize neuron by changing extracellular K+ concentration.
Volume 13, Issue 4, Pages (October 2015)
Eleanor H. Simpson, Christoph Kellendonk, Eric Kandel  Neuron 
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Volume 97, Issue 4, Pages e6 (February 2018)
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Veena Venkatachalam, Adam E. Cohen  Biophysical Journal 
Targeting Neural Circuits
Silencing Neurons: Tools, Applications, and Experimental Constraints
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

OPTOGENETICS and Caged compounds Saad Abbasi, Lindsey Biggs and Brennan Paedae

History of the development of optogenetics Paper published by Chow et al, (2010) using archaerhodopsin which completely shuts down the cell. Three-gene phototransduction cascade used to activate cells Collaboration between Nagel, and Deisseroth (and Boyden) Halorhodopsin used for neural silencing Discovery and study of opsins 1970’s 1999 Paper on channelrhodopsin published by Georg Nagel et al. (2003) Halorhodopsin and neural chloride levels First published paper using optogenetics (Boyden et al., 2005) on cultured hippocampal neurons, followed by papers from several other labs Papers published using OptoXR, light activated GPCR’s which modulate intracellular signalling (Aiden,2009) and use in live primates (Han et al. 2009) Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?) Photo: Halobacterium salinarum http://www.biochem.mpg.de/en/eg/oesterhelt/web_page_list/Org_Hasal/index.html

1970-1980’s Discovery and study of opsins Halobacterium salinarum: Motile organisms Can live with light as the only energy source (Bacteriorhodopsin) 4 retinal proteins: Bacteriorhodopsin: light driven proton pump that converts light to energy source [discovered in early 1970’s (Boyden, 2011)] Halorhodopsin: chloride pump that maintains salt concentration [discovered in late 1970’s (Boyden, 2011)] Sensory rhodopsin 1:phototactic response to orange light [discovered in 1980’s (Boyden, 2011)] Sensory rhodopsin 2: phototactic response to blue light. BUT….. The organisms expressing these rhodopsins function in environments with high salt concentrations, so there was little optimism for function in neural tissue. http://www.mpi-magdeburg.mpg.de/research/groups/mna/smallnet.html?pp=1 http://www.biochem.mpg.de/en/eg/oesterhelt/web_page_list/Org_Hasal/index.html

1999 Halorhopsin and neural chloride levels Okuno et al. re-opened the possibility of using rhodopsins in neural tissue with his 1999 paper. Compared to H. salinarum, rhodopsins from Natronomona pharaonis functioned best at chloride concentrations that are similar to concentrations seen in neural tissue. BUT….. It was still unknown whether these rhodopsins could be expressed and functional in neural tissue.

History of the development of optogenetics Paper published by Chow et al, (2010) using archaerhodopsin which completely shuts down the cell. Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Halorhodopsin used for neural silencing Discovery and study of opsins 1970’s 1999 2002 Paper on channelrhodopsin published by Georg Nagel et al. (2003) Halorhodopsin and neural chloride levels First published paper using optogenetics (Boyden et al., 2005) on cultured hippocampal neurons, followed by papers from several other labs Papers published using OptoXR, light activated GPCR’s which modulate intracellular signalling (Aiden,2009) and use in live primates (Han et al. 2009) Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?) Photo: chARGe in cultured hippocampal neuron (GFP tagged) (Zemelman, 2002)

2002 chARGe may be the answer! Gero Miesenbrook and colleagues created a three-gene Drosophilia phototransduction cascade that could be expressed in cultured hippocampal neurons. When exposed to light, cells expressing chARGe were more active. (Zemelman, 2002). chARGe= Arrestin-2 rhodopsin coupled to alpha subunit of g-protein. However, the activation of neurons was not instantaneous, but took several seconds. A temporally precise method of activation was still necessary.

History of the development of optogenetics Paper published by Chow et al, (2010) using archaerhodopsin which completely shuts down the cell. Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Halorhodopsin used for neural silencing Discovery and study of opsins 2003 2004 1970’s 1999 2002 Let there be light! Channelrhopsin 2 is light sensitive. Halorhodopsin and neural chloride levels First published paper using optogenetics (Boyden et al., 2005) on cultured hippocampal neurons, followed by papers from several other labs Papers published using OptoXR, light activated GPCR’s which modulate intracellular signalling (Aiden,2009) and use in live primates (Han et al. 2009) Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?) Photo: ChR2 conjugated to RFP http://en.wikipedia.org/wiki/Channelrhodopsin

2003 and 2004 Channelrhodopsin-2 Chlamydomona reinhardtii use channelrhodopsin-2 (ChR2) to drive phototaxis (Sineshchekov et al. 2002). ChR2 is a light gated cation channel which produces movement in C. reinhardtii. Nagel and colleaques used ChR2 in oocytes and HEK cells to show that it could be used to depolarize cells via illumination (Nagel et al. 2003). In 2004, a collaboration between Georg Nagel, Karl Deisseroth (and Edward Boyden) began. Nagel had since discovered that not much all-trans retinal needed to be added to the cultures for ChR2 function. Boyden, 2011

History of the development of optogenetics Paper published by Chow et al, (2010) using archaerhodopsin which completely shuts down the cell. Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Halorhodopsin used for neural silencing Discovery and study of opsins 2003 2004 2005 1970’s 1999 2002 Let there be light! Channelrhopsin 2 is light sensitive. First published paper using optogenetics (Boyden et al., 2005). Halorhodopsin and neural chloride levels Papers published using OptoXR, light activated GPCR’s which modulate intracellular signalling (Aiden,2009) and use in live primates (Han et al. 2009) Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?) Photo: ChR2 response to light (cultured hippocampal neuron) (Boyden, 2011 from Boyden et al. 2005 paper)

2005 First published paper using optogenetics In 2005, Edward Boyden, Karl Deisseroth and colleagues published the first paper using optogentics in cultured mammalian hippocampal neurons. ChR2 was expressed, and functional in neurons. Current produced by ChR2 activation was enough to produce action potentials. ChR2 had a low rate of inactivation and quick recovery time. Several other labs published papers using similar techniques soon after. These methods had been on the minds of many research groups! Yawo Lab – 11/05- intact mammal brain circuits Herlitze and Landmesser labs-11/05 chick spinal cord Nagel and Gottschalk labs-12/05; behaving worm Pan Lab- 4/06; retina (Boyden, et al. 2005)

History of the development of optogenetics Paper published by Chow et al, (2010) using archaerhodopsin which completely shuts down the cell. Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Halorhodopsin used for neural silencing Discovery and study of opsins 2003 2004 2005 2007 1970’s 1999 2002 Let there be light! Channelrhopsin 2 is light sensitive. First published paper using optogenetics (Boyden et al., 2005). Halorhodopsin and neural chloride levels Papers published using OptoXR, light activated GPCR’s which modulate intracellular signalling (Aiden,2009) and use in live primates (Han et al. 2009) Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?) Photo: Halorhodpsin Lief et al., 2011

2007 N. pharaonis Halorhodpsin March 2007-Xue Han and Boyden published data showing that N. Pharaonis halorhodopsin could be used for neural silencing. (Cl- channel) Few weeks later, Karl et al published a paper showing the same conclusion and that it could be used to modify behavior in C. elegans. BUT…..halorhodopsin had low magnitude currents, would get stuck in inactivation phase after long stimulation, and had a slow recovery period. (Boyden, 2011)

History of the development of optogenetics Paper published by Chow et al, (2010) using archaerhodopsin which completely shuts down the cell. Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Halorhodopsin used for neural silencing Discovery and study of opsins 2003 2004 2005 2007 2009 1970’s 1999 2002 Let there be light! Channelrhopsin 2 is light sensitive. Papers published on optogenetics in primates. First published paper using optogenetics (Boyden et al., 2005). Halorhodopsin and neural chloride levels Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?)

2009 Optogenetics in primates Boyden and Desimone published research on primate brains, suggesting these methods could someday be used for clinical purposes. Conclusions: ChR2 can be expressed in maquaqe monkeys to modulate activity in specific subsets of neurons, without inducing neuron death and immune responses.

History of the development of optogenetics Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Archaerhodopsin completely silences neurons. Halorhodopsin used for neural silencing Discovery and study of opsins 2003 2004 2005 2007 2009 2010 1970’s 1999 2002 Let there be light! Channelrhopsin 2 is light sensitive. Papers published on optogenetics in primates. First published paper using optogenetics (Boyden et al., 2005). Halorhodopsin and neural chloride levels Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures (Palle Lab?)

2010 Arechearhodopsin The solution to the limitations of halorhodopsin: Archearhodopsin The paper published in Jan 2010 by Chow and Boyden showed that archearhodopsin: Could completely shut down the cell. Had rapid recovery after long stimulation hyperpolarize the cell by pumping protons out of the cell (Chow et al. 2010).

History of the development of optogenetics Collaboration between Nagel, and Deisseroth (and Boyden) Three-gene phototransduction cascade used to activate cells Archaerhodopsin completely silences neurons. Halorhodopsin used for neural silencing Discovery and study of opsins 2011 2003 2004 2005 2007 2009 2010 1970’s 1999 2002 Let there be light! Channelrhopsin 2 is light sensitive. Papers published on optogenetics in primates. First published paper using optogenetics (Boyden et al., 2005). Halorhodopsin and neural chloride levels Use of nanoparticles and magnetic pulses to activate specific cell types without such invasive measures Photo:Arnd Pralle, physics prof. at Univ of Buffalo. Research on magnetic nanoparticles

Parkinson’s Disease Degenerative disorder of the CNS. Most cases occur after the age of 50 Causes: Death of cells in the Substantia nigra which produce dopamine. Cause of cell loss is unknown, but is genetic is some cases. Symptoms: Movement-related: shaking (tremor), rigidity, slow movements, difficulty walking and with gait postural instability. Cognitive and behavioral problems in more advanced stages: dementia, sensory, sleep and emotional problems. Diagnosis is usually based on symptoms, with neuroimaging used for confirmation. Treatments: L-Dopa (which can cross the BBB) and other dopamine agonists. With the loss of DA producing neurons, these treatments become ineffective and can cause diskinesia (involuntary writhing movements) Deep-brain stimulation and lesion surgery are used as a last resort. www.wikipedia.org

Basal ganglia circuitry Substantia nigra pars reticulata Substantia nigra pars reticulata Substantia nigra pars reticulata http://www.ncbi.nlm.nih.gov/books/NBK10847/

ChR2 was expressed in medium spiny neurons (DARPP-32 MSN marker) D1-Cre mice expressed ChR2-YFP in striatum and fibers projecting through globus pallidus to SNr. D2-Cre mice, ChR2- YFP cells bodies were seen in striatum, projecting to globus pallidus. ChR2 was expressed in medium spiny neurons (DARPP-32 MSN marker) Supp. Fig. 1

Whole cell slice electrophysiology Whole cell slice eletrophysiology was used to verify ChR2 expression in D1 and D2 specific neurons. Current-firing relationship for direct and indirect pathways were consistent with previous data (a,b) 470 nm illumination of the ChR2 expressing neurosn produced light-evoked inward current and increased spiking. A-D= slice. A,B= whole cell current clamp demonstrates normal current-firing relationship in ChR2-YFP neurons (direct pathway-red, indirect- green) C,D= ChR2 mediated current and spiking in direct and indirect pathways. Illumination produced firing.

In vivo laser stimulation and recording Silicon probe with integrated laser-couple optical fiber. In vivo laser stimulation and recording Inset- supplemental fig 5. 16 site- silicon probe with integrated laser-coupled optical fibre to elicit light induced spiking up to 800 uM from tip. E. Exp design to show that illumination in vivo evokes spiking. F,G,H= Illumination= increased spiking in D1 or D2 neurons during laser, but not pre or post. Responses in35% of neurons recorded. I- schematic of SNr recording. Remember to mention SNr recieves input from striatum MSNs either directly or indirectly. Inhibitory to thalamus during no movement. J, I= Direct pathway= recieves input from striatum, is inhibited, projects to thalamus, (inhibition of GABA neurons disinhibits thalamus.) K, I=Indirect pathway= receives input from Gpe (DA in striatum = inhibition of D2 putaman disinhibit Gpeinhibit STNreduces excitation of SNr release of inhibition to thal. NOTE:::in K the D2 neurons are being excited, therefore, you see an increase in firing in SNr. OPPOSITE effect of DA release in striatum.

Behavioral data Activation of direct pathway (D1) increased percent of time in ambulation, and decreased freezing and fine motor movements. Activation of indirect pathway (D2) decreased ambulation and fine movements and increased the time spent freezing. Direct pathway activation: decrease in freezing, fine movements. Increase in ambulation. more frequent and longer ambulatory bouts Less frequent and shorter freezing bouts Indirect pathway activation decreased ambulation and fine movements, increased freezing less frequent and shorter bouts of ambulation. more frequent and longer freezing bouts Causal relationship between direct pathway in increasing motor behavior and between indirect pathway and increased freezing responses.

Bilateral stimulation of indirect pathway

Bilateral 6-OHDA injections caused loss of dopaminergic innervation in dorsomedial striatum and Parkinsonian- like motor deficits. Activation of the direct pathway completely restored pre-lesion motor behaviors. Decreased freezing Increased locomotor activity.

Restoration of motor behaviors by direct pathway activation

Conclusions: This study provides evidence in a behaving animal that activation of the direct and indirect pathways are modulating motor activity as previously suggested. This technique offers temporally precise activation of the circuitry (compared to pharmacological blockade, lesions, or transgenic mice). This technique also allows for a quick return to baseline firing rates and activity. Activation of the direct pathway in basal ganglia can ameliorate motor deficits caused by loss of striatal neurons (which are modulated by DA release from substantia nigra.)

Halorhopsin from H. salinarum functions best at high chloride levels Halorhopsin from H. salinarum functions best at high chloride levels. (Left) Halorhopsin from N. pharaonis functions best at lower chloride concentrations, which are similar to neural tissue. (Okuno et al., 1999)

Lindsey Biggs and Brennan Paedae http://www.fmls-institute.de/index.php?id=neurobiochemistry http://blogs.physicstoday.org/industry09/ https://encrypted-tbn0.google.com/images?q=tbn:ANd9GcQL5mvVzT07u1TnAgnMC7QStw5V2BJ3-5ytYFM5lVolKD34QkoEKQ OPTOGENETICS http://www.aan.com/elibrary/neurologytoday/?event=home.showArticle&id=ovid.com:/bib/ovftdb/00132985-201107070-00006 http://czechfood.blogspot.com/2011/07/optogenetics-optogenetica.html Lindsey Biggs and Brennan Paedae http://www.stanford.edu/~shenoy/GroupResearchPublications.htm http://www.nytimes.com/2011/05/17/science/17optics.html?_r=1 https://encrypted-tbn1.google.com/images?q=tbn:ANd9GcQVAQDbKMATn9SkXr45jkleAr9O9HqOum4wjihhLB4161OkhNO68w